Model Details

Patient Information for Model: BCM-PDAC-29

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-PDAC-29

Model Details
Mutations
There are no omics data for this model.

CNV


Metastasis Information for Model: BCM-PDAC-29
 
Patient
PDX
Liver
Local recurrence
Lung
Rectum
lymph node

Patient Treatment Information for Model: BCM-PDAC-29

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseReason Stopped
10Gemcitabine/capecitabineadjuvant 65.6165.92113 daysComplete Response (CR); "No evidence of disease" Completed regimen
15chemo/radiation adjuvant 66.0366.1336 daysComplete Response (CR); "No evidence of disease" Completed regimen
20Gemcitabine/Abraxaneadjuvant 67.1767.2322 daysStopped due to side effects
25Gemcitabine adjuvant 67.3467.3815 daysProgressive Disease (PD)Stopped due to disease progression
30Gemcitabine/Capecitabine adjuvant 67.4467.6784 daysUnknownCompleted regimen












Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.